Application 202946
- Type
- ANDA
- Sponsor
- SPECGX LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 5MG | No | No |
| 002 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 7.5MG | No | No |
| 003 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 10MG | No | No |
| 004 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 15MG | No | No |
| 005 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 20MG | No | No |
| 006 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 30MG | No | No |
| 007 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 40MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202946-001 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | 5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | ||
| A202946-002 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | 7.5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | ||
| A202946-003 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | ||
| A202946-004 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | 15MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | ||
| A202946-005 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | 20MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | ||
| A202946-006 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | 30MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | ||
| A202946-007 | OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | 40MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A202946-001 | OXYMORPHONE HYDROCHLORIDE | 5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A202946-002 | OXYMORPHONE HYDROCHLORIDE | 7.5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A202946-003 | OXYMORPHONE HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A202946-004 | OXYMORPHONE HYDROCHLORIDE | 15MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A202946-005 | OXYMORPHONE HYDROCHLORIDE | 20MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A202946-006 | OXYMORPHONE HYDROCHLORIDE | 30MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A202946-007 | OXYMORPHONE HYDROCHLORIDE | 40MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202946-001 | OXYMORPHONE HYDROCHLORIDE | 5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202946-002 | OXYMORPHONE HYDROCHLORIDE | 7.5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202946-003 | OXYMORPHONE HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202946-004 | OXYMORPHONE HYDROCHLORIDE | 15MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202946-005 | OXYMORPHONE HYDROCHLORIDE | 20MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202946-006 | OXYMORPHONE HYDROCHLORIDE | 30MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202946-007 | OXYMORPHONE HYDROCHLORIDE | 40MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202946-001 | OXYMORPHONE HYDROCHLORIDE | 5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202946-002 | OXYMORPHONE HYDROCHLORIDE | 7.5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202946-003 | OXYMORPHONE HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202946-004 | OXYMORPHONE HYDROCHLORIDE | 15MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202946-005 | OXYMORPHONE HYDROCHLORIDE | 20MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202946-006 | OXYMORPHONE HYDROCHLORIDE | 30MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202946-007 | OXYMORPHONE HYDROCHLORIDE | 40MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202946-001 | OXYMORPHONE HYDROCHLORIDE | 5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202946-002 | OXYMORPHONE HYDROCHLORIDE | 7.5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202946-003 | OXYMORPHONE HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202946-004 | OXYMORPHONE HYDROCHLORIDE | 15MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202946-005 | OXYMORPHONE HYDROCHLORIDE | 20MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202946-006 | OXYMORPHONE HYDROCHLORIDE | 30MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202946-007 | OXYMORPHONE HYDROCHLORIDE | 40MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202946-001 | OXYMORPHONE HYDROCHLORIDE | 5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202946-002 | OXYMORPHONE HYDROCHLORIDE | 7.5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202946-003 | OXYMORPHONE HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202946-004 | OXYMORPHONE HYDROCHLORIDE | 15MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202946-005 | OXYMORPHONE HYDROCHLORIDE | 20MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202946-006 | OXYMORPHONE HYDROCHLORIDE | 30MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202946-007 | OXYMORPHONE HYDROCHLORIDE | 40MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202946-001 | OXYMORPHONE HYDROCHLORIDE | 5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202946-002 | OXYMORPHONE HYDROCHLORIDE | 7.5MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202946-003 | OXYMORPHONE HYDROCHLORIDE | 10MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202946-004 | OXYMORPHONE HYDROCHLORIDE | 15MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202946-005 | OXYMORPHONE HYDROCHLORIDE | 20MG | TABLET, EXTENDED RELEASE / ORAL | 2014-06-27 | b8a1b40f171c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A202946-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A202946-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A202946-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A202946-004 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A202946-005 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A202946-006 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A202946-007 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A202946-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A202946-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A202946-003 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A202946-004 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A202946-005 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A202946-006 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A202946-007 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A202946-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A202946-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A202946-003 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A202946-004 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A202946-005 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A202946-006 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A202946-007 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A202946-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A202946-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A202946-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A202946-004 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A202946-005 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A202946-006 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A202946-007 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxymorphone Hydrochloride | OXYMORPHONE HYDROCHLORIDE | Aurolife Pharma, LLC | 22c7652a-aa16-4fa8-89d9-517e69059068 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | Oxymorphone Hydrochloride OXYMORPHONE HYDROCHLORIDE |
| Oxymorphone Hydrochloride | OXYMORPHONE HYDROCHLORIDE | KVK-Tech, Inc. | dcb5b5d2-7d0a-497a-8f1e-3b96fd43320b | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | Oxymorphone Hydrochloride OXYMORPHONE HYDROCHLORIDE |
| Oxymorphone hydrochloride | OXYMORPHONE HYDROCHLORIDE | Amneal Pharmaceuticals LLC | 3f4e703a-e398-42fd-8759-e398c79955f1 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | Oxymorphone hydrochloride OXYMORPHONE HYDROCHLORIDE |
| Oxymorphone Hydrochloride | OXYMORPHONE HYDROCHLORIDE | Epic Pharma, LLC | 95804e72-232d-425d-b23d-a66f43bdf0c6 | 2025-12-15 | Boxed warning, Warnings, Adverse reactions | Oxymorphone Hydrochloride OXYMORPHONE HYDROCHLORIDE |
| Oxymorphone Hydrochloride | OXYMORPHONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 3eb971cf-ab82-49f3-a46c-4d76a8ce599e | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | Oxymorphone Hydrochloride OXYMORPHONE HYDROCHLORIDE |
| OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | Camber Pharmaceuticals, Inc | 06af7dff-c261-4c03-9cd9-0605c42507fa | 2025-08-18 | Boxed warning, Warnings, Adverse reactions | OXYMORPHONE HYDROCHLORIDE OXYMORPHONE HYDROCHLORIDE |
| Oxymorphone hydrochloride | OXYMORPHONE HYDROCHLORIDE | Amneal Pharmaceuticals of New York LLC | 557e9610-62d7-42bf-90c1-44215bd8c1f8 | 2024-01-10 | Boxed warning, Warnings, Adverse reactions | Oxymorphone hydrochloride OXYMORPHONE HYDROCHLORIDE |
| OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | Bryant Ranch Prepack | 560e9425-dfcb-4fb4-a759-b1e3f8f40fdb | 2024-01-09 | Boxed warning, Warnings, Adverse reactions | OXYMORPHONE HYDROCHLORIDE OXYMORPHONE HYDROCHLORIDE |
| OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | XLCare Pharmaceuticals, Inc. | 1a1d5061-b62a-49fa-a5b2-4970f51416ae | 2020-05-07 | Boxed warning, Warnings, Adverse reactions | OXYMORPHONE HYDROCHLORIDE OXYMORPHONE HYDROCHLORIDE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0406-8091 | Oxymorphone Hydrochloride | Oxymorphone Hydrochloride | SpecGx LLC | ANDA | Current |
| 0406-8092 | Oxymorphone Hydrochloride | Oxymorphone Hydrochloride | SpecGx LLC | ANDA | Current |
| 0406-8093 | Oxymorphone Hydrochloride | Oxymorphone Hydrochloride | SpecGx LLC | ANDA | Current |
| 0406-8094 | Oxymorphone Hydrochloride | Oxymorphone Hydrochloride | SpecGx LLC | ANDA | Current |
| 0406-8095 | Oxymorphone Hydrochloride | Oxymorphone Hydrochloride | SpecGx LLC | ANDA | Current |
| 0406-8096 | Oxymorphone Hydrochloride | Oxymorphone Hydrochloride | SpecGx LLC | ANDA | Current |
| 0406-8097 | Oxymorphone Hydrochloride | Oxymorphone Hydrochloride | SpecGx LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 24109 | ORIG | 2015-06-30 |